Cronos Group (TSE:CRON) Releases Quarterly Earnings Results

Cronos Group (TSE:CRON) released its quarterly earnings results on Monday. The company reported C$0.06 EPS for the quarter, FiscalAI reports. Cronos Group had a negative return on equity of 0.87% and a negative net margin of 6.37%.The business had revenue of C$62.86 million during the quarter.

Cronos Group Trading Up 8.1%

CRON stock opened at C$3.75 on Tuesday. The company has a market capitalization of C$1.41 billion, a PE ratio of -187.50, a price-to-earnings-growth ratio of 0.12 and a beta of 1.12. Cronos Group has a one year low of C$2.54 and a one year high of C$4.66. The company’s 50 day moving average price is C$3.56 and its two-hundred day moving average price is C$3.60. The company has a debt-to-equity ratio of 0.25, a quick ratio of 24.01 and a current ratio of 19.59.

Analysts Set New Price Targets

Several research firms have recently commented on CRON. Canaccord Genuity Group set a C$4.25 price target on Cronos Group and gave the stock a “buy” rating in a research report on Tuesday, January 27th. TD Securities set a C$4.50 price target on Cronos Group and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of C$4.38.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.